SCHEMBL13124705

SCHEMBL13124705

OCCN1C=C/C(=C\C=C\c2sc3ccc(Cl)cc3[n+]2CCO)c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
USP2 O75604 1/20 0.34
MTOR P42345 1/20 0.34
PRMT5 O14744 1/20 0.34
CARM1 Q86X55 1/20 0.34
PRMT1 Q99873 1/20 0.34
MEN1 O00255 6/20 0.33
KMT2A Q03164 6/20 0.33
HTT P42858 4/20 0.33
MAPT P10636 4/20 0.33
THRB P10828 4/20 0.33
MAPK1 P28482 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
BLM P54132 4/20 0.33
L3MBTL1 Q9Y468 3/20 0.32
APAF1 O14727 1/20 0.32
APP P05067 1/20 0.32
ITGB2 P05107 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26845462 0.95 PRMT5 (0.34) NPC1RAB9AUSP2MTORPRMT5
SCHEMBL13124537 0.93 NPC1 (0.42) NPC1RAB9AUSP2MTORPRMT5
SCHEMBL26845464 0.92 MEN1 (0.33) NPC1RAB9AUSP2PRMT5CARM1
SCHEMBL26845470 0.90 KMT2A (0.42) NPC1RAB9AUSP2MTORMEN1
SCHEMBL13108258 0.89 NPC1 (0.43) NPC1RAB9AUSP2MTORMEN1
SCHEMBL26845402 0.88 PRMT5 (0.34) PRMT5CARM1PRMT1
SCHEMBL26845542 0.86 NPC1 (0.43) NPC1RAB9AUSP2MTORPRMT5
SCHEMBL26845364 0.86 NPC1 (0.37) NPC1RAB9AUSP2MTORPRMT5
SCHEMBL26845388 0.85 PRMT1 (0.40) PRMT5CARM1PRMT1
SCHEMBL26845406 0.85 PRMT1 (0.42) NPC1RAB9AUSP2MTORPRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940499-B2 Reagent for blood analysis and method of use thereof SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) 2015-01-27 US disclosed
US-20100267080-A1 REAGENT FOR BLOOD ANALYSIS AND METHOD OF USE THEREOF SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) 2010-10-21 US disclosed
US-7709653-B2 Asymmetric cyanine compounds, their preparation methods and their uses SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD. (CN) 2010-05-04 US disclosed
US-20090305285-A1 ASYMMETRIC CYANINE COMPOUNDS, THEIR PREPARATION METHODS AND THEIR USES SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) 2009-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090305285-A1 ASYMMETRIC CYANINE COMPOUNDS, THEIR PREPARATION METHODS AND THEIR USES IK, RCN1, RCC1 NPC1 2415/4885RAB9A 3144/4885USP2 4372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.